I now have all the information needed to give comprehensive answers to all 5 questions. Let me compile the full response.
Here are detailed answers to all five sub-questions (5 x 2 marks each):
3a. Why is Probenecid combined with Penicillin?
Probenecid is a uricosuric drug that inhibits the organic acid (anionic) transporter in the renal tubules. This transporter is responsible for the active secretion of penicillin into the tubular lumen for urinary excretion.
When probenecid is given alongside penicillin:
- It competitively blocks the renal tubular secretion of penicillin
- This decreases penicillin clearance, resulting in higher and more sustained plasma concentrations
- The terminal half-life of penicillin is prolonged
This combination was historically important when penicillin was scarce and expensive - the same therapeutic effect could be achieved with a smaller dose. It is still used today in regimens where high, sustained penicillin levels are required (e.g., treatment of gonorrhea or neurosyphilis).
(Goldman-Cecil Medicine, Goodman & Gilman's Pharmacological Basis of Therapeutics)
3b. Why is Levodopa combined with Carbidopa in treatment of Parkinsonism?
Levodopa is the precursor to dopamine, but when given alone, it is extensively metabolized in the periphery (gut wall, liver) by the enzyme dopa decarboxylase (DDC) into dopamine. Peripheral dopamine cannot cross the blood-brain barrier, so it is therapeutically useless but causes significant side effects (nausea, vomiting, cardiac arrhythmias, postural hypotension).
Carbidopa is a peripheral dopa decarboxylase inhibitor that:
- Does not cross the blood-brain barrier (lacks a transport mechanism)
- Inhibits DDC only in peripheral tissues
- Reduces peripheral conversion of levodopa to dopamine by ~75%
- Allows much more levodopa to reach the brain (higher CNS bioavailability)
- Reduces peripheral side effects (less nausea, vomiting, cardiovascular effects)
- Allows a significantly lower dose of levodopa to be used (reduces required dose by 75-80%)
The combination is the most effective symptomatic treatment for the motor disturbances of Parkinsonism.
(Katzung's Basic and Clinical Pharmacology, 16th Ed.)
3c. Why is Rifabutin preferred over Rifampicin in treating Tuberculosis with HIV patients?
This comes down to drug interactions via CYP450 enzyme induction:
Rifampicin is a potent inducer of CYP3A4 (and other CYP enzymes). HIV-positive TB patients are usually on antiretroviral therapy (ART) - particularly protease inhibitors (PIs) or NNRTIs (e.g., nevirapine, efavirenz). Rifampicin dramatically reduces plasma levels of antiretrovirals by accelerating their metabolism, potentially leading to virological failure and resistance.
Rifabutin, in contrast:
- Is a weaker CYP3A4 inducer than rifampicin
- Has less impact on antiretroviral plasma concentrations
- Can be co-administered with most PIs and NNRTIs (with dose adjustments)
- Provides equivalent anti-TB efficacy
Therefore, rifabutin is the preferred rifamycin in HIV-TB co-infected patients on ART to avoid the catastrophic drug interaction that rifampicin would cause.
(Goodman & Gilman's, Harriet Lane Handbook)
3d. Why should exogenous steroid therapy not be stopped abruptly?
Prolonged exogenous corticosteroid therapy (prednisone >7.5-10 mg/day for weeks to months) causes suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis via negative feedback. The hypothalamus and pituitary "sense" high glucocorticoid levels and stop producing CRH and ACTH, leading to adrenal cortex atrophy and loss of ability to produce endogenous cortisol.
If corticosteroids are stopped abruptly:
- The adrenal glands cannot immediately resume normal cortisol production
- The patient develops acute adrenal insufficiency (Addisonian crisis)
- This is potentially life-threatening
Symptoms of adrenal crisis include:
- Nausea, vomiting, fever, dehydration
- Severe hypotension and shock
- Hypoglycemia and hyperkalemia
Additionally, abrupt withdrawal may cause disease flare of the underlying condition being treated.
Therefore, steroids must be tapered slowly and gradually to allow the HPA axis to recover, monitored carefully.
(Lippincott Illustrated Reviews Pharmacology; Goodman & Gilman's)
3e. Why is Primaquine used for Radical Cure in Malaria?
Malaria caused by Plasmodium vivax and P. ovale has a unique feature: after infecting the liver, these parasites form dormant liver stages called hypnozoites. These remain latent in the hepatocytes for weeks, months, or even years and are responsible for relapses of malaria long after the initial infection appears to be cleared.
Standard blood schizonticides (e.g., chloroquine, artemisinin-based combinations) eliminate the erythrocytic (blood) stages of the parasite but have no activity against hypnozoites in the liver.
Primaquine is the only drug that:
- Has high activity against the dormant hepatic hypnozoites (tissue schizonticidal / anti-hypnozoite action)
- Can therefore achieve a "radical cure" - eradicating both blood-stage and liver-stage parasites, preventing future relapses
- Is given alongside a blood schizonticide (usually chloroquine) for complete effect
Without primaquine, only a clinical/suppressive cure is achieved (symptoms clear but relapses occur). Radical cure requires complete elimination of all parasite stages, which only primaquine (or the newer tafenoquine) can accomplish.
Note: G6PD deficiency must be screened for before use, as primaquine can cause serious hemolytic anemia in G6PD-deficient individuals.
(Goodman & Gilman's Pharmacological Basis of Therapeutics; Katzung's Basic and Clinical Pharmacology; Harrison's Principles of Internal Medicine 22E)